Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fojo

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Genes, Chromosomes & Cancer|August 26, 1998
Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALLT Knutsen, L A Mickley, T Ried, et al.
AIDS (London, England)|August 1, 2024
The anxiety care continuum and its association with viral suppression among persons with HIVLauren C Zalla, Heidi E Hutton, Anthony T Fojo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2026
The Potential Effect of Ending CDC Funding for HIV Tests: A Modeling Study in 18 StatesRuchita Balasubramanian, Melissa Schnure, Ryan Forster, et al.
Journal of Surgical Oncology|September 1, 2022
Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancerAlexander S Thomas, Wooil Kwon, David P Horowitz, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
The Potential Effect of Ending CDC Funding for HIV Tests: A Modeling Study in 18 StatesRuchita Balasubramanian, Melissa Schnure, Ryan Forster, et al.
The Journal of Infectious Diseases|October 4, 2023
Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and DisparityOluwaseun Falade-Nwulia, Catherine R Lesko, Anthony T Fojo, et al.
Chembiochem : a European Journal of Chemical Biology|February 6, 2002
Synthesis and biological evaluation of 12,13-cyclopropyl and 12,13-cyclobutyl epothilonesK C Nicolaou, K Namoto, J Li, et al.
Cancer|December 18, 2001
A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar)S Bates, M Kang, B Meadows, et al.
European Journal of Epidemiology|September 18, 2024
Cohort profile update: the Johns Hopkins HIV clinical cohort, 1989-2023Catherine R Lesko, Anthony T Fojo, Jeanne C Keruly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2022
Time Between Viral Loads for People With HIV During the COVID-19 PandemicWalid G El-Nahal, Nicola M Shen, Jeanne C Keruly, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Genes, Chromosomes & Cancer|August 26, 1998
Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALLT Knutsen, L A Mickley, T Ried, et al.
AIDS (London, England)|August 1, 2024
The anxiety care continuum and its association with viral suppression among persons with HIVLauren C Zalla, Heidi E Hutton, Anthony T Fojo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2026
The Potential Effect of Ending CDC Funding for HIV Tests: A Modeling Study in 18 StatesRuchita Balasubramanian, Melissa Schnure, Ryan Forster, et al.
Journal of Surgical Oncology|September 1, 2022
Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancerAlexander S Thomas, Wooil Kwon, David P Horowitz, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
The Potential Effect of Ending CDC Funding for HIV Tests: A Modeling Study in 18 StatesRuchita Balasubramanian, Melissa Schnure, Ryan Forster, et al.
The Journal of Infectious Diseases|October 4, 2023
Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and DisparityOluwaseun Falade-Nwulia, Catherine R Lesko, Anthony T Fojo, et al.
Chembiochem : a European Journal of Chemical Biology|February 6, 2002
Synthesis and biological evaluation of 12,13-cyclopropyl and 12,13-cyclobutyl epothilonesK C Nicolaou, K Namoto, J Li, et al.
Cancer|December 18, 2001
A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar)S Bates, M Kang, B Meadows, et al.
European Journal of Epidemiology|September 18, 2024
Cohort profile update: the Johns Hopkins HIV clinical cohort, 1989-2023Catherine R Lesko, Anthony T Fojo, Jeanne C Keruly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2022
Time Between Viral Loads for People With HIV During the COVID-19 PandemicWalid G El-Nahal, Nicola M Shen, Jeanne C Keruly, et al.
Pageof 18